These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 37550019)

  • 1. Efficacy of single-dose oral secnidazole for the treatment of trichomoniasis in women co-infected with trichomoniasis and bacterial vaginosis: a post hoc subgroup analysis of phase 3 clinical trial data.
    Muzny CA; Van Gerwen OT; Kaufman G; Chavoustie S
    BMJ Open; 2023 Aug; 13(8):e072071. PubMed ID: 37550019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and Safety of Single Oral Dosing of Secnidazole for Trichomoniasis in Women: Results of a Phase 3, Randomized, Double-Blind, Placebo-Controlled, Delayed-Treatment Study.
    Muzny CA; Schwebke JR; Nyirjesy P; Kaufman G; Mena LA; Lazenby GB; Van Gerwen OT; Graves KJ; Arbuckle J; Carter BA; McMahon CP; Eder S; Shaw J; Pandey B; Chavoustie SE
    Clin Infect Dis; 2021 Sep; 73(6):e1282-e1289. PubMed ID: 33768237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secnidazole for Trichomoniasis in Women and Men.
    Muzny CA; Van Gerwen OT
    Sex Med Rev; 2022 Apr; 10(2):255-262. PubMed ID: 35153156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phase-3, double-blind, placebo-controlled study of the effectiveness and safety of single oral doses of secnidazole 2 g for the treatment of women with bacterial vaginosis.
    Schwebke JR; Morgan FG; Koltun W; Nyirjesy P
    Am J Obstet Gynecol; 2017 Dec; 217(6):678.e1-678.e9. PubMed ID: 28867602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vulvovaginitis: screening for and management of trichomoniasis, vulvovaginal candidiasis, and bacterial vaginosis.
    van Schalkwyk J; Yudin MH;
    J Obstet Gynaecol Can; 2015 Mar; 37(3):266-274. PubMed ID: 26001874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-dose versus 7-day-dose metronidazole for the treatment of trichomoniasis in women: an open-label, randomised controlled trial.
    Kissinger P; Muzny CA; Mena LA; Lillis RA; Schwebke JR; Beauchamps L; Taylor SN; Schmidt N; Myers L; Augostini P; Secor WE; Bradic M; Carlton JM; Martin DH
    Lancet Infect Dis; 2018 Nov; 18(11):1251-1259. PubMed ID: 30297322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secnidazole: a treatment for trichomoniasis in adolescents and adults.
    Muzny CA; Van Gerwen OT; Legendre D
    Expert Rev Anti Infect Ther; 2022 Aug; 20(8):1067-1076. PubMed ID: 35642509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secnidazole Treatment of Bacterial Vaginosis: A Randomized Controlled Trial.
    Hillier SL; Nyirjesy P; Waldbaum AS; Schwebke JR; Morgan FG; Adetoro NA; Braun CJ
    Obstet Gynecol; 2017 Aug; 130(2):379-386. PubMed ID: 28697102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Integrated Efficacy and Safety Analysis of Single-Dose Secnidazole 2 g in the Treatment of Bacterial Vaginosis.
    Pentikis H; Adetoro N; Tipping D; Levy S
    Reprod Sci; 2020 Feb; 27(2):523-528. PubMed ID: 32046418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secnidazole for treatment of bacterial vaginosis: a systematic review.
    Abd El Aziz MA; Sharifipour F; Abedi P; Jahanfar S; Judge HM
    BMC Womens Health; 2019 Oct; 19(1):121. PubMed ID: 31638955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secnidazole: next-generation antimicrobial agent for bacterial vaginosis treatment.
    Nyirjesy P; Schwebke JR
    Future Microbiol; 2018 Apr; 13():507-524. PubMed ID: 29327947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of bacterial vaginosis on the response to Trichomonas vaginalis treatment among HIV-infected women.
    Gatski M; Martin DH; Levison J; Mena L; Clark RA; Murphy M; Henderson H; Schmidt N; Kissinger P
    Sex Transm Infect; 2011 Apr; 87(3):205-8. PubMed ID: 21278401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Validation of a Test for the Diagnosis of Vaginitis.
    Gaydos CA; Beqaj S; Schwebke JR; Lebed J; Smith B; Davis TE; Fife KH; Nyirjesy P; Spurrell T; Furgerson D; Coleman J; Paradis S; Cooper CK
    Obstet Gynecol; 2017 Jul; 130(1):181-189. PubMed ID: 28594779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secnidazole. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic use in the management of protozoal infections and bacterial vaginosis.
    Gillis JC; Wiseman LR
    Drugs; 1996 Apr; 51(4):621-38. PubMed ID: 8706597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Phase 3, Multicenter, Prospective, Open-Label Study to Evaluate the Safety of a Single Dose of Secnidazole 2 g for the Treatment of Women and Postmenarchal Adolescent Girls with Bacterial Vaginosis.
    Chavoustie SE; Gersten JK; Samuel MJ; Schwebke JR
    J Womens Health (Larchmt); 2018 Apr; 27(4):492-497. PubMed ID: 29323627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful treatment with secnidazole for trichomoniasis in the setting of metronidazole hypersensitivity.
    Kufel WD; Asiago-Reddy EA; Parsels KA; Sanyal S; Coyne JL
    Int J STD AIDS; 2021 Nov; 32(13):1271-1273. PubMed ID: 34392726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-dose secnidazole in the treatment of bacterial vaginosis.
    Núñez JT; Gómez G
    Int J Gynaecol Obstet; 2005 Mar; 88(3):281-5. PubMed ID: 15733882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of single dose of oral secnidazole 2 g in treatment of bacterial vaginosis: A systematic review and meta-analysis.
    Elghazaly SM; Hamam KM; Badawy MM; Yakoub Agha NA; Samy A; Abbas AM
    Eur J Obstet Gynecol Reprod Biol; 2019 Jul; 238():125-131. PubMed ID: 31129560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A cross-sectional analysis of
    Bochner AF; Baeten JM; Rustagi AS; Nakku-Joloba E; Lingappa JR; Mugo NR; Bukusi EA; Kapiga S; Delany-Moretlwe S; Celum C; Barnabas RV;
    Sex Transm Infect; 2017 Nov; 93(7):520-529. PubMed ID: 28377421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Association Between Human Immunodeficiency Virus and Bacterial Vaginosis and Metronidazole Treatment Failure for Trichomonas vaginalis.
    Frechtling D; Chopra S; Ratnayake A; Kissinger PJ
    Sex Transm Dis; 2024 Jan; 51(1):61-64. PubMed ID: 37921835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.